期刊文献+

药物代谢清除率体外预测模型研究进展与问题分析 被引量:4

Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs
下载PDF
导出
摘要 本文介绍了药物代谢清除率临床前预测的相关理论和数学模型,从而将所得的体外代谢清除率数据用于肝清除率的推算,并根据国内外学者对该预测方法准确度评估及体内体外相关性考察,指出该研究领域中出现的难点和可能的改进方案;以期使体内代谢行为的预测更加准确,并对尽早确定创新药物在人体内药物代谢动力学行为是否适合进行进一步研究开发具有重要的指导意义,并为今后创新药物的研发提供新的思路。 The reasonable prediction of metabolic clearance rate from the humanized in vitro system is valuable in drug discovery, which is commonly used in the identification and optimization of compounds that mostly like to process appropriate pharmacokinetic characteristics in humans. A detailecl development of the general theory and, models underlying the prediction of in vivo hepatic drug metabolism from in vitro data were presented. Furthermore, the accuracy when extrapolating from in vitro data considering the in vitro-in vivo correlation, method-logical issues and potential solutions were discussed as well. This review can give us a better insight into exploring methods whereby human clearance can be accurately predicted from in vitro data in the process of new drug development.
作者 张倩 王广基
出处 《药学学报》 CAS CSCD 北大核心 2007年第10期1023-1028,共6页 Acta Pharmaceutica Sinica
基金 国家高技术研究发展计划(863计划)资助项目(2003AA2Z347A 2005AA2Z3C70).
关键词 代谢清除率 药物代谢动力学 体内-体外相关性 metabolic clearance rate pharmacokinetics in vitro-in vivo correlation
  • 相关文献

参考文献3

二级参考文献30

  • 1戴垚,刘秀均,甄永苏.抗IV型胶原酶单抗与平阳霉素新型免疫偶联物的抗肿瘤作用[J].药学学报,2006,41(1):41-46. 被引量:16
  • 2Westerink BH,Tuinte MH.Chronie use of intracerebral dialysis for the in vivo measurement of 3,4-dihydroxyphenylethylamine and its metabolite 3,4-dihydroxyphenylethylacetic acid[J].J Neurochem,1986,46:181.
  • 3Boschi G,Scherrmann JM.Microdialysis in mice for drug delivery research[J].Adv Drug Deliv Rev,2000,45:271 -281.
  • 4Wood PL,Kim HS,Stocklin K,et al.Dynamic of striatal 3-MT pool in rat and mouse:species differences as assessed by steady-state measurements and intracerebral dialysis[J].Life Sci,1988,42:2275 -2281.
  • 5de Lange EC,de Bock G,Schinkel AH,et al.BBB transport and P-glycoprotein functioality using mdrla(-/-) and wild-type mice.Total brain versus microdialysis concentration profiles of rhodamine-123[J].Pharm Res,1998,15:1657-1665.
  • 6de Lange EC,Marchand S,van den Berg D,et al.In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin[J].Eur J Pharm Sci,2000,12:85 -93.
  • 7Evrard PA,Deridder G,Verbeeck RK.Intravenous microdialysis in the mouse and the rat:development and pharmacokinetic application of a new probe[J].Pharm Res,1996,13:12-17.
  • 8Deterding LJ,Dix KL,Burka T,et al.On-line coupling of in vivo microdialysis with tandem mass spectrometry[J].Anal Chem,1992,64:2636.
  • 9Aguirre N,Beal MF,Matson WR,et al.Increased oxidative damage to DNA in an animal model of amyotrophic lateral sclerosis[J].Free Radic Res,2005,39:383 -388.
  • 10Franklin KBJ,Paxinos G.The Mouse Brain in Stereotaxic Coordinates[M].San Diego:Academic Press,1997.

共引文献16

同被引文献77

  • 1李强,步秀云,章国良,楼雅卿.HPLC法测定大鼠血浆中氯桂丁胺浓度[J].药物分析杂志,2004,24(3):279-281. 被引量:1
  • 2薛永志,章国良,步秀云.氯桂丁胺对小鼠CYP450含量的影响及与大鼠血浆蛋白结合率[J].包头医学院学报,2005,21(4):339-341. 被引量:2
  • 3Prentis RA, Lis Y, Walker SR. Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985)[J] . Br J Clin Pharmacol, 1988,25(3) : 387-396.
  • 4Ismail K, John L. Can the pharmaceutical industry reduce attrition rates? [J] . Nat Rev Drug Discov, 2004,3(8): 711-715.
  • 5Obach R, Baxter J. The prediction of human phar macokinetic parameters from preclinical and in vitro metabolism data[J] . J Pharmacol Exp Ther, 1997, 283(1) : 46-57.
  • 6Wajima T, Fukumura K, Yano Y, et al. Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: volume of distribution at steady state[J] . J Pharm Pharmacol, 2003,55(7): 939-949.
  • 7Clausen J , BickeI MH. Prediction of drug distribution in distribution dialysis and in vivo from binding to tissues and blood[J] . J PharmSci, 1993,82(4): 345-349.
  • 8Loren MB, Jonathan R, Xuhai B, et al. Prediction of Vss from in vitro tissue-binding studies[J] . Drug Metab Dispos, 2010,38(1) :115-121.
  • 9Poulin P, Schoenlein K, Theil FP. Prediction of adipose tissue: plasma partition coefficients for struc- turally unrelated drugs[J]. J Pharm Sci,2001,90 (4) :436-447.
  • 10Poulin P, Theil FP. A priori prediction of tissue: plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drugdiscovery[J]. J PharmSci, 2000,89(1) :16--35.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部